D
Douglas J. Pritchard
Researcher at Mayo Clinic
Publications - 125
Citations - 12485
Douglas J. Pritchard is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Sarcoma & Ewing's sarcoma. The author has an hindex of 57, co-authored 125 publications receiving 11855 citations. Previous affiliations of Douglas J. Pritchard include Argonne National Laboratory.
Papers
More filters
Journal ArticleDOI
A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system.
TL;DR: The need for a standardized system of end result reporting of various surgical alternatives after limb salvaging and ablative procedures for musculoskeletal tumors was clearly recognized during the first International Symposium on Limb Salvage in 1981.
Journal ArticleDOI
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Holcombe E. Grier,Mark Krailo,Nancy J. Tarbell,Michael P. Link,Chris Fryer,Douglas J. Pritchard,Mark C. Gebhardt,Paul S. Dickman,Elizabeth J. Perlman,Paul A. Meyers,Sarah S. Donaldson,Sheila Moore,Aaron R. Rausen,Teresa J. Vietti,James S. Miser +14 more
TL;DR: The addition of ifosfamide and etoposide to a standard regimen does not affect the outcome for patients with metastatic disease, but it significantly improves the outcomeFor patients with nonmetastatic Ewing's Sarcoma, primitive neuroectodermal tumor of bone, or primitive sarcoma of bone.
Journal ArticleDOI
A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results.
TL;DR: The preliminary conclusion is that elective node dissection is not beneficial in management of melanoma, and disease progression was advanced significantly by age of the patient and by invasiveness and thickness of the melanoma.
Journal ArticleDOI
Extra-abdominal desmoid tumors.
TL;DR: Recommendations are made for wide local excision when anatomically feasible or marginal excision and postoperative radiation therapy when function of the extremity would be severely compromised if excision with wide margins were done.
Journal ArticleDOI
Metastases from histologically benign giant-cell tumor of bone.
TL;DR: Eight cases from the experience of more than 400 cases of histologically benign giant-cell tumor of bone are added, advising aggressive attempts at complete extirpation of metastases.